Učitavanje...
Therapeutic Targets for Multiple Sclerosis: Current Treatment Goals and Future Directions
Multiple sclerosis (MS) is an autoimmune demyelinating disease of the central nervous system, and the most common cause of nontraumatic disability in young adults. Most patients have a relapsing–remitting course, and roughly half of them will eventually enter a degenerative progressive phase, marked...
Spremljeno u:
| Izdano u: | Neurotherapeutics |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer US
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5722758/ https://ncbi.nlm.nih.gov/pubmed/28653282 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-017-0548-5 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|